본문 바로가기
KERD
논문KCI 등재

Stereoselective Bioreduction of Ethyl 3-Oxo-3-(2-Thienyl) Propanoate Using the Short-Chain Dehydrogenase/Reductase ChKRED12

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Ethyl (S)-3-hydroxy-3-(2-thienyl) propanoate ((S)-HEES) acts as a key chiral intermediate for the blockbuster antidepressant drug duloxetine, which can be achieved via the stereoselective bioreduction of ethyl 3-oxo-3-(2-thienyl) propanoate (KEES) that contains a 3-oxoacyl structure. The sequences of the short-chain dehydrogenase/reductases from Chryseobacterium sp. CA49 were analyzed, and the putative 3-oxoacyl-acyl-carrier-protein reductase, ChKRED12, was able to stereoselectively catalyze the NADPH-dependent reduction to produce (S)-HEES. The reductase activity of ChKRED12 towards other substrates with 3- oxoacyl structure were confirmed with excellent stereoselectivity (>99% enantiomeric excess) in most cases. When coupled with a cofactor recycling system using glucose dehydrogenase, the ChKRED12 was able to catalyze the complete conversion of 100 g/l KEES within 12 h, yielding the enantiopure product with >99% ee, showing a remarkable potential to produce (S)-HEES.

Abstract

Ethyl (S)-3-hydroxy-3-(2-thienyl) propanoate ((S)-HEES) acts as a key chiral intermediate for the blockbuster antidepressant drug duloxetine, which can be achieved via the stereoselective bioreduction of ethyl 3-oxo-3-(2-thienyl) propanoate (KEES) that contains a 3-oxoacyl structure. The sequences of the short-chain dehydrogenase/reductases from Chryseobacterium sp. CA49 were analyzed, and the putative 3-oxoacyl-acyl-carrier-protein reductase, ChKRED12, was able to stereoselectively catalyze the NADPH-dependent reduction to produce (S)-HEES. The reductase activity of ChKRED12 towards other substrates with 3- oxoacyl structure were confirmed with excellent stereoselectivity (>99% enantiomeric excess) in most cases. When coupled with a cofactor recycling system using glucose dehydrogenase, the ChKRED12 was able to catalyze the complete conversion of 100 g/l KEES within 12 h, yielding the enantiopure product with >99% ee, showing a remarkable potential to produce (S)-HEES.

참고문헌 (43)

  1. Balke K, "Discovery, application and protein engineering of BaeyerVilliger monooxygenases for organic synthesis", Org. Biomol. Chem, 10, pp.6249~6265 (2012)
  2. Bornscheuer UT, "Engineering the third wave of biocatalysis", Nature, 485, pp.185~194 (2012)
  3. Deshpande PP, "Microbial hydroxylation of obromophenylacetic acid : synthesis of 4-substituted-2, 3dihydrobenzofurans", J. Ind. Microbiol. Biotechnol, 35, pp.901~906 (2008)
  4. Hollmann F, "Enzymatic reductions for the chemist", Green Chem, 13, pp.2285~2314 (2011)
  5. Ni Y, "Biocatalytic ketone reduction : a green and efficient access to enantiopure alcohols", Biotechnol. Adv, 30, pp.1279~1288 (2012)
  6. Ren Z-Q, "Bioreductive production of enantiopure(S)-duloxetine intermediates catalyzed with ketoreductase ChKRED15", J. Mol. Catal. B Enzym, 113, pp.76~81 (2015)
  7. Tang C-G, "Highly enantioselective bioreduction of N-methyl-3-oxo-3(thiophen-2-yl)propanamide for the production of(S)duloxetine", Biotechnol. Lett, 33, pp.1435~1440 (2011)
  8. Wada M, "Cloning and overexpression of the Exiguobacterium sp, F42 gene encoding a new short chain dehydrogenase, which catalyzes the stereoselective reduction of ethyl 3-oxo-3-(2-thienyl) propanoate to ethyl (S)-3-hydroxy3-(2-thienyl) propanoate", Biosci. Biotechnol. Biochem, 68, pp.1481~1488 (2004)
  9. Liu H, "Chemo-enzymatic synthesis of the antidepressant duloxetine and its enantiomer", Chirality, 12, pp.26~29 (2000)
  10. Bymaster F, "Duloxetine(Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake", Bioorg. Med. Chem. Lett, 13, pp.4477~4480 (2003)
  11. Deeter J, "Asymmetric synthesis and absolute stereochemistry of LY248686", Tetrahedron Lett, 31, pp.7101~7104 (1990)
  12. Nakamura K, "Recent developments in asymmetric reduction of ketones with biocatalysts", Tetrahedron Asymmetry, 14, pp.2659~2681 (2003)
  13. Goldberg K, "Biocatalytic ketone reduction—a powerful tool for the production of chiral alcohols-part II : whole-cell reductions", Appl. Microbiol. Biotechnol, 76, pp.249~255 (2007)
  14. Sun T, "Enhancement of asymmetric bioreduction of N, N-dimethyl-3-keto-3-(2-thienyl)1-propanamine to corresponding(S)-enantiomer by fusion of carbonyl reductase and glucose dehydrogenase", Bioresour. Bioprocess, 4, pp.21~ (2017)
  15. Toomey RE, "Studies on the mechanism of fatty acid synthesis, XVI. Preparation and general properties of acyl-malonyl acyl carrier protein-condensing enzyme from Escherichia coli", J. Biol. Chem, 241, pp.1159~1165 (1966)
  16. Fisher M, "The X-ray structure of Brassica napus βketo acyl carrier protein reductase and its implications for substrate binding and catalysis", Structure, 8, pp.339~347 (2000)
  17. Birge CH, "Acyl carrier protein, XVI. Intermediate reactions of unsaturated fatty acid synthesis in Escherichia coli and studies of fab B mutants", J. Biol. Chem, 247, pp.4921~4929 (1972)
  18. Prelog V, "Specification of the stereospecificity of some oxidoreductases by diamond lattice sections", Pure Appl. Chem, 9, pp.12~ (1964)
  19. Huisman GW, "Practical chiral alcohol manufacture using ketoreductases", Curr. Opin. Chem. Biol, 14, pp.122~129 (2010)
  20. Tasnádi G, "Relevant practical applications of bioreduction processes in the synthesis of active pharmaceutical ingredients", Synth. Methods Biol. Act. Mol, pp.329~374 (2013)
  21. Liu Y, "Identification of ketone reductase ChKRED20 from the genome of Chryseobacterium sp, CA49 for highly efficient anti-Prelog reduction of 3, 5-bis (trifluoromethyl) acetophenone", J. Mol. Catal. B Enzym, 102, pp.1~8 (2014)
  22. Ratovelomanana-Vidal V, "Enantioselective hydrogenation of β-keto esters using chiral diphosphine-ruthenium complexes : optimization for academic and industrial purposes and synthetic applications", Adv. Synth. Catal, 345, pp.261~274 (2003)
  23. 3-Hydroxy-3-(2-Thienyl)Propionamide Compound, Process For Producing The Same, And Process For Producing 3-Amino-1-(2-Thienyl)-1-Propanol Compound Therefrom, "Takehara J", ~ (2004)
  24. Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors, "Boulet SL", ~ (2004)
  25. Jung J, "Asymmetric synthesis of (S)-ethyl-4-chloro-3-hydroxy butanoate using a Saccharomyces cerevisiae reductase: enantioselectivity and enzyme-substrate docking studies", Biochim. Biophys. Acta, 1804, pp.1841~1849 (2010)
  26. Oppermann U, "Short-chain dehydrogenases", reductases (SDR):the 2002 update, 2003, pp.143-144, 247~253
  27. Duax WL, "Divergent evolution of a Rossmann fold and identification of its oldest surviving ancestor", Int. J. Bioinform. Res. Appl, 5, pp.280~294 (2009)
  28. Keller B, "Bioinformatic identification and characterization of new members of short-chain dehydrogenase", reductase superfamily, 2006, pp.248, 56~60
  29. Kallberg Y, "Short-chain dehydrogenase", reductase(SDR)relationships : a large family with eight clusters common to human, animal, and plant genomes, 2002, pp.11, 636~641
  30. Rafferty JB, "Common themes in redox chemistry emerge from the X-ray structure of oilseed rape(Brassica napus)enoyl acyl carrier protein reductase", Structure, 3, pp.927~938 (1995)
  31. reductase from Spinacia oleracea leaves, "Arch. Biochem. Biophys", 1982, 77~91
  32. Kavanagh KL, "Medium-and short-chain dehydrogenase", reductase gene and protein families : the SDR superfamily : functional and structural diversity within a family of metabolic and regulatory enzymes, 2008, pp.65, 3895~3906
  33. Kim TS, "A highly efficient sorbitol dehydrogenase from Gluconobacter oxydans G624 and improvement of its stability through immobilization", Sci. Rep, 6, pp.33438~ (2016)
  34. Cui D, "Computational design of short-chain dehydrogenase Gox2181 for altered coenzyme specificity", J. Biotechnol, 167, pp.386~392 (2013)
  35. reductase from oilseed rape(Brassica napus), "Biochim. Biophys. Acta", 1992, 151~159
  36. Fisher M, "The X-ray structure of Brassica napus beta-keto acyl carrier protein reductase and its implications for substrate binding and catalysis", Structure, 8, pp.339~347 (2000)
  37. Ramachandran P, "Role of the non-conserved amino acid asparagine 285 in the glycone-binding pocket of Neosartorya fischeri β-glucosidase", RSC Adv, 6, pp.48137~48144 (2016)
  38. Selvaraj C, "Structural insights into the binding mode of d-sorbitol with sorbitol dehydrogenase using QMpolarized ligand docking and molecular dynamics simulations", Biochem. Eng. J, 114, pp.244~256 (2016)
  39. Cai P, "Development of a substrate-coupled biocatalytic process driven by an NADPH-dependent sorbose reductase from Candida albicans for the asymmetric reduction of ethyl 4chloro-3-oxobutanoate", Biotechnol. Lett, 34, pp.2223~2227 (2012)
  40. Wang LJ, "Highly efficient synthesis of chiral alcohols with a novel NADHdependent reductase from Streptomyces coelicolor", Bioresour. Technol, 102, pp.7023~7028 (2011)
  41. Zhao FJ, "Rapid asymmetric reduction of ethyl 4-chloro-3-oxobutanoate using a thermostabilized mutant of ketoreductase ChKRED20", Appl. Microbiol. Biotechnol, 100, pp.3567~3575 (2016)
  42. Brem J, "Lipases A and B from Candida antarctica in the enantioselective acylation of ethyl 3-heteroaryl-3hydroxypropanoates : aspects on the preparation and enantiopreference", Tetrahedron Asymmetry, 22, pp.315~322 (2011)
  43. Soni P, "Biotransformations for the production of the chiral drug(S)-Duloxetine catalyzed by a novel isolate of Candida tropicalis", Appl. Microbiol. Biotechnol, 67, pp.771~777 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (8건)